Phathom Pharmaceuticals (PHAT) Q4 2024 Earnings

7NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-1.56
-1.4
-1.24
-1.08

Details

Expected EPS
-1.468647
Actual EPS
-1.32
Surprise EPS
0.15
Surprise Percent
+10.12%

Description

Phathom Pharmaceuticals (PHAT) has reported earnings of -1.32 per share for Q4 2024.

0 Comments

Share your thoughts